Current controversies in prenatal diagnosis 1: NIPT for chromosome abnormalities should be offered to women with low a priori risk
作者： Jan M. M. Van Lith , Brigitte H. W. Faas , Diana W. Bianchi
DOI: 10.1002/PD.4530
关键词:
摘要: In its successful annual cycle of controversies and debates, the International Society Prenatal Diagnosis Therapy once again addressed non-invasive prenatal testing (NIPT) by following up on 2013 controversy, 'Should DNA be standard screening test for Down syndrome in all pregnant women'? with proposition, 'NIPT chromosomel abnormalities should offered to women low a priori risk'.
ru.nl
core.ac.uk
sci-hub.se 参考文章(27)
C. Michael Osborne, Emily Hardisty, Patricia Devers, Kathleen Kaiser-Rogers, Melissa A. Hayden, William Goodnight, Neeta L. Vora, Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease Prenatal Diagnosis. ,vol. 33, pp. 609- 611 ,(2013) , 10.1002/PD.4100
Yijun Song, Congcong Liu, Hong Qi, Yunping Zhang, Xuming Bian, Juntao Liu, Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population Prenatal Diagnosis. ,vol. 33, pp. 700- 706 ,(2013) , 10.1002/PD.4160
Nancy C. Rose, Danielle Lagrave, Brent Hafen, Marc Jackson, The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine. Prenatal Diagnosis. ,vol. 33, pp. 242- 244 ,(2013) , 10.1002/PD.4052
James Maxwell Glover Wilson, Gunnar Jungner, World Health Organization, None, Principles and practice of screening for disease ,(1968)
Peter Benn, Antoni Borrell, Howard Cuckle, Lorraine Dugoff, Susan Gross, Jo-ann Johnson, Ron Maymon, Anthony Odibo, Peter Schielen, Kevin Spencer, Dave Wright, Yuval Yaron, Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011 Prenatal Diagnosis. ,vol. 32, pp. 1- 2 ,(2012) , 10.1002/PD.2919
Wylie Burke, Genetic tests: clinical validity and clinical utility. Current protocols in human genetics. ,vol. 81, ,(2014) , 10.1002/0471142905.HG0915S81
Peter Benn, Audrey R. Chapman, Kristine Erickson, Mark S. DeFrancesco, Louise Wilkins-Haug, James F. X. Egan, Jay Schulkin, Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing Prenatal Diagnosis. ,vol. 34, pp. 145- 152 ,(2014) , 10.1002/PD.4272
Watson Ms, Holtzman Na, Promoting safe and effective genetic testing in the United States. Final report of the Task Force on Genetic Testing. Journal of child and family nursing. ,vol. 2, pp. 388- ,(1999)
K. H. Nicolaides, D. Wright, L. C. Poon, A. Syngelaki, M. M. Gil, First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing Ultrasound in Obstetrics & Gynecology. ,vol. 42, pp. 41- 50 ,(2013) , 10.1002/UOG.12511
Stephen Morris, Saffron Karlsen, Nancy Chung, Melissa Hill, Lyn S Chitty, None, Model-Based Analysis of Costs and Outcomes of Non-Invasive Prenatal Testing for Down’s Syndrome Using Cell Free Fetal DNA in the UK National Health Service PLoS ONE. ,vol. 9, pp. e93559- ,(2014) , 10.1371/JOURNAL.PONE.0093559